 |
Tentative Agenda:
As macroeconomic forces create challenging headwinds across the investment landscape, venture capital firms are eyeing segments such as cleantech and biotech in addition to emerging markets. But cross-border deals present unique challenges, while the regulatory environment offers other hurdles as well. Still, there are opportunities in the market as companies aim for second-, third- and fourth- rounds of funding as young start-ups also prowl for a piece of the pie.
As a result, themes of the conference include, but are not limited to:
- M&A Trends: Recent Transactions, Challenges and Outlook
Alternative Sources of Financing in the Post-Credit Crunch Environment
Secondary Markets
Sovereign Wealth Funds - Friend or Foe?
FASB 157 - What You Need to Know About Valuations?
Infrastructure Investing Opportunities
Cleantech Plays for Private Equity Industry
Developing Industry-wide Compliance Standards: Views of Regulators and LPs
Raising Your Next Fund
SPAC Life Cycle: Raising the Fund, Searching for Targets, Completing the Deal
Cross-border Transactions: Capturing Growth of the Global Economy
Private Equity Opportunities in Emerging Markets
Post-Merger Integration Challenges: IT, Human Capital and Operations
Leveraged ESOP Buyouts 101
|
|
 |
 |
November 5, 2008
8:00am – 6:00pm
Boston, MA
Event Price: $875
Event location will be disclosed to attendees upon completion of the registration process.
Event Overview
Tentative Agenda
Keynote Speakers
Sponsors
Support the Event
Co-Hosts
Attendee Policy
Attendee Refund Policy
Conference Content
Travel & Other Information
Conference Packs
Soft Dollar Application
Registration will not be available onsite at this event
* Please note that we have a limited allocation of tickets for members of the advisory community. The tickets are $1800 and are available on a first come first served basis.
|